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BACKGROUND: Stromal tumors of the jejunum (GIST) and omentum (EGIST) are uncommon and 
dearth of information still exists on their occurrence concurrently.  
CASE DETAILS: Here, we report a nine year old girl that presented with tender abdominal mass 
measuring 14 x 8 cm associated with features of gastric outlet obstruction and hyponatremia of 
115mmol/L. A diagnosis of hyponatremia in a child with gastric outlet obstruction secondary to intra-
abdominal mass was made for which exploratory laparotomy was carried out. Histology of the tumour 
revealed stromal spindle epithelioid as well as myxoid cells. Complete resection of the tumour and 
correction for hyponatremia was done in addition to antibiotics therapy with remarkable improvement. 
CONCLUSION: Index case is that of mixed stromal tumours that presented with features of gastric 
outlet obstruction, and the patient did well after surgery. 
KEYWORDS: Gastrointestinal/extraintestinal stromal tumors, Jejunum, Omentum, Paediatrics, 
Adamawa state, Nigeria.  
 
INTRODUCTION    
 
Gastrointestinal stromal tumor (GIST) is a rare 
form of soft tissue sarcoma of the gastrointestinal 
tract. This has led to GIST being classified under 
smooth muscles neoplasm of the gastrointestinal 
tract by earlier workers (1). Walker and Dvorak 
(2), in 1986, however, revealed that smooth 
muscle differentiation is usually absent in a 
typical case of GIST. Mazur and Clark (3), in 
1983 have identified that leiomyomas that lacked 
smooth muscle cells and immunohistochemical 
features of Schwann cells were also classified as 
GIST. More recently, Hirota and collogues (4), 
found that GIST arises from interstitial cells of 
Cajal on the submucosal and myenteric plexus of 
the gastrointestinal tract. Many workers have 
used the term GIST to signify mesenchymal 
tumors arising from the submucosa of the 
gastrointestinal tract thereby indicating a shift 
from smooth muscles neoplasm nomenclature to 
a more appropriate term called GIST (1-5).  
Gastrointestinal stromal tumor occurs in 
about 2/100,000 population (5). Of this 60% 
occurs in the stomach, 30% in the ileum, 5% in 
the duodenum, rarely from the colorectal, 
esophagus and appendix, and extremely rare from 
the jejunum (1, 5, 6). Reith et al in 2000 reported 
another rare GIST that originates outside the 
gastrointestinal tract; this was termed 
extraintestinal GIST (EGIST) (7). Stromal 
tumors in general could be seen as a wide 
spectrum of tumors with origin from the intestine 
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Here, we report a rare mix of GIST/EGIST 
arising from the duodenum and omentum of nine  
nine years old girl at the Department of 
Paediatrics, Federal Medical Centre Yola, 
Adamawa state Nigeria.  
 
CASE Details  
 
A 9 year old girl presented with a huge painful 
abdominal swelling associated with projectile 
vomiting. A firm tender mass measuring 14 x 8 
cm was palpated extending from the left 
hypochondriac, periumblical to the right 
hypogastrium. Abdominal ultrasonography 
showed hypoechoeic mass occupying almost the 
entire quadrants of the abdomen. Abdominal X-
ray (Fig 1) showed a mass with features of gastric 
outlet obstruction (massive gastric shadow 
ascending up to the level of the thoracic cavity 
obscuring the left cardiac border and meniscal 
sign, however, no areas of calcification were 
observed. There was hyponatremia of 
115mmol/L, other laboratory profiles and 
haemogram were normal. Lack of facility 
hindered us from doing computed tomography 
(CT) of the abdomen. A diagnosis of 
hyponatremia in a child with gastric outlet 
obstruction secondary to intra-abdominal mass 
was entertained. At laparotomy a tumor (Fig 2a) 
was found on the jejunum and the omentum 
extending to the level of the bladder with 
adhesions, however, no evidence of metastasis in 
the abdominal cavity. Histology of the resected 
tumour specimen subsequently revealed 
proliferating stromal spindle, epithelioid and 
myxoid cells in line with the diagnosis of GIST 
(Fig 2b). Patient had complete resection of the 
tumor, correction for hyponatremia in addition to 
antibiotics with remarkable improvement. She 
was subsequently discharged on follow up visits. 
 
 
   
 
 
Fig 1: Abdominal X-ray (yellow arrows shows huge gastric shadow with diaphragmatic elevation 
distorting the left cardiac silhouette. Black arrow indicates meniscal sign, while green arrow point to left 
hypochondriac part of the mass 
 






 Fig 2: a) Macroscopic appearance of the resected tumour and b) Histologic image of the resected 




Stromal tumors whether GIST or EGIST 
originates primarily from mesenchymal 
interstitial cells of Cajal (1, 5, 6). Our patient 
presented with two very rare types of stromal 
tumors that were found on the jejunum and the 
omentum. Literature search on GIST/EGIST 
occurring simultaneously on a patient such as 
ours revealed dearth of information, however, 
many authors have found GIST or EGIST to 
occur as an entity.  Alexander et al (1), in 2012 in 
Germany and Dhull et al (5), in 2011 in India 
have identified EGIST and GIST independently 
occurring on patients. Patients with this condition 
may be asymptomatic, which was not the case in 
our patient (1-7). Patients can also present with 
painful abdominal mass, mechanical obstruction 
and bleeding (5). These features were evident in 
our present case except bleeding. Histology and 
Immunocytochemical studies are important 
among other investigative measures used in 
making the diagnosis of GIST, however, facility 
for the latter is lacking in our centre. Other 
investigative findings may not be specific for 
GIST. In fact, diagnosis of GIST on CT imaging 
becomes very difficult if the mass is small and 
lacks ulceration and necrosis (5). Bleeding was 
not manifest in our patient, she was not pale and 
her haemogram was normal, these exclude the 
possibility of ulceration and necrosis.  
From the explanation proffered above, CT 
imaging may have been fruitless even if facility 
for it is available in our setting. In such cases 
histopathology is often required for confirming 
the diagnosis as was done in this case report. 
Histology in index case showed predominantly 
spindle cell tumors, which agreed to findings by 
other investigators (6). Other histologic types 
such as epithelioid and myxoid variants were also 
observed in recent case as documented in other 
studies (2-4, 7). Of note is that histology unlike in 
other tumours does not determine outcome of 
GIST (6). Miettinen and colleague (8), in 2006 
have argued that tumor size, which indirectly 
reflects mitotic activity, gives better prognostic 
features. Another study further stated that tumor 
size above 10 cm has a poor outcome due to 
possible metastasis that is observed with huge 
tumors (9). On this basis, our patient may be 
having un-favorable prognostic feature because 
her tumor size was beyond 10cm. However, no 
visible features of metastases were observed 
during surgery. Mutation involving tyrosine 
kinase proteins leading to gain of function 
remains vital in the pathogenesis of GIST (1, 5, 
6, 8). Thus, tyrosine kinase inhibitor Imatinib has 
been successfully used in the treatment of 
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metastatic GIST and EGIST in addition to 
preventing relapse for many years (8).  
Imatinib can kill GIST cells that have 
metastasized to other parts of the body and 
cannot be surgically removed. Because cells of 
GIST depend on activation of growth pathways 
for their proliferation, withdrawal of this pathway 
may lead to their death through a mechanism 
called apoptosis (8, 9). Treatment of GIST with 
Imatinib has effectively resulted in the 
withdrawal of growth factor pathway leading to 
apoptosis. Theoretically, our patient could benefit 
from this drug because she had omental stromal 
tumour (EGIST) couple with the fact that 
microscopic metastasis may have set in due to 
her massive tumour size. Practically, Imatinib, is 
not readily available in our hospital and Nigeria 
at large. Reasons for this may be due to its rare 
indication in terms of usage, as such, it does not 
form part of our essential drugs list. Moreover, 
omental stromal tumours are rare making it 
difficult to study effectively their malignant 
tendencies and response to Imatinib (5). Despite 
this setback, most patients may not require the 
drug because cure can be achieved by surgery 
even though relapse after surgery has been 
published (1, 5, 6).   
We presented a case of mixed stromal tumours 
involving the jejunum and omentum associated 
with features of gastric outlet obstruction, which 
responded to surgical treatment. Because omental 
EGIST are known for their relapse, drug 
treatment in addition to surgery is advised, but 
due to lack of this drug in our center, our patient 
did not benefit from it. However, we are 
recommending Imatinib therapy as an adjuvant to 
surgical intervention in order to prevent relapse 
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